相关实验视频
Updated: Jun 10, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
40
在临床前的关节炎模型中,IDO2通过抑制B细胞中的Runx1功能来驱动自身抗体的产生和关节炎症
Weidan Peng1, Lauren M F Merlo1, Samantha Grabler1
1Lankenau Institute for Medical Research, Wynnewood, PA.
Journal of immunology (Baltimore, Md. : 1950)
|October 14, 2024
概括
印度醇胺2,3-二氧化酶2 (IDO2) 通过抑制B细胞中的Runx1功能来驱动自身免疫性关节炎. 针对IDO2-Runx1相互作用,为自身免疫性疾病提供了一种新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 类风湿病学 类风湿病学
背景情况:
- 印度列胺2,3-二氧化酶2 (IDO2) 涉及到自身免疫性关节炎.
- IDO2的前关节炎功能涉及一种非酶途径,与其托-催化作用不同.
- Runx1 (与Runt相关的转录因子1) 是IDO2非酶途径中的潜在调解者.
研究的目的:
- 研究IDO2和Runx1在自身免疫性关节炎中的相互作用.
- 为了确定Runx1是否在B细胞中调解IDO2的前关节炎作用.
- 评估针对 IDO2-Runx1 相互作用的治疗潜力.
主要方法:
- 生物化学试验证实了Runx1.1的IDO2结合和核局部抑制.
- 在关节炎模型中生成B细胞条件的Runx1缺乏的小鼠.
- 在体外和体内实验中使用抗IDO2单克隆抗体 (mAbs) 的实验.
主要成果:
- IDO2直接结合Runx1并抑制其核转位.
- 在IDO2存在的情况下,Runx1缺乏不会影响关节炎,但会逆转IDO2损失的抗关节炎作用.
- 在体外和体内阻断IDO2-Runx1与抗IDO2 mAb抑制关节炎的相互作用.
结论:
- IDO2通过抑制B细胞中的Runx1功能来促进自身抗体的产生和关节炎症.
- IDO2-Runx1轴是IDO2-介导关节炎下游关键通路.
- 向IDO2-Runx1结合是一种有前途的治疗策略,用于自身免疫性关节炎和相关疾病.
相关概念视频
T Cell Types and Functions
959
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
959
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Autoimmune Disorders
392
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
392
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K

